Ardelyx Inc

ARDX

NASDAQ. Currency in USD

1.86 +0.01 ( +0.54% )

Real time prices: December 05

Market Cap.
348.67M
Beta (5Y monthly)
1.47
Price/Earnings
-
EPS (TTM)
-0.85
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
5.21M
1y Target Est.
6.59
Day's Range
1.84
-
1.98
52 Week's Range
0.49
-
2.19

Historical Summary

Performance
EPS growth
Share Buybacks

About Ardelyx Inc

Sector
Healthcare
Industry
Biotechnology
Website
https://www.ardelyx.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
112.74M
Employees
86
Address
400 Fifth Avenue, Waltham, MA, United States, 02451
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD. The company has agreements with Kyowa Kirin in Japan, Fosun Pharmaceutical Industrial Development Co. Ltd. in China, and Knight Therapeutics, Inc. in Canada for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Latest news

Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday

U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here...
By Benzinga - 1 week ago

Penny Stocks To Buy: 7 Insider Picks For November 2022
Penny Stocks To Buy: 7 Insider Picks For November 2022

Penny stocks to buy according to insiders in November 2022. The post Penny Stocks To...
By PennyStocks - 2 weeks ago

Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday

Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday....
By Benzinga - 2 weeks ago

Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday
Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday

U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here...
By Benzinga - 2 weeks ago

What Do Penny Stocks Need to Succeed in 2022? 
What Do Penny Stocks Need to Succeed in 2022? 

This is what penny stocks need to succeed in 2022 The post What Do Penny...
By PennyStocks - 2 weeks ago

2 Biotech Stocks That Can Rocket Higher in 2023, According to Wall Street
2 Biotech Stocks That Can Rocket Higher in 2023, According to Wall Street

Recent analyst upgrades suggest these stocks can triple your money or better.
By The Motley Fool - 2 weeks ago

Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session

Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity...
By Benzinga - 2 weeks ago